Paper published in a journal (Scientific congresses and symposiums)
Safety analysis of BOLERO-3 : a phase III trial of daily Everolimus vs placebo, both with weekly Trastuzumab and Vinorelbine in Trastuzumab-resistant, advanced breast cancer
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Masuda, Norikazu; Osaka National Hospital, Osaka, Japan
Andre, Fabrice; Institut Gustave Roussy - IGR
Fein, Luis; Instituto de Oncologia de Rosario, Argentina
Fasolo, Angelica; San Raffaele Hospital, Milan, Italy
O'Regan, Ruth; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA
Wilks, Sharon; Cancer Care Centers of South Texas, San Antonio, Texas, USA
Isaacs, Claudine; Department of Medicine, Georgetown University, Washington DC, USA
Zhang, Yufen; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
Taran, Tetiana; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
Toi, Masakazu; Department of Surgery, Kyoto University, Kyoto, Japan
Language :
English
Title :
Safety analysis of BOLERO-3 : a phase III trial of daily Everolimus vs placebo, both with weekly Trastuzumab and Vinorelbine in Trastuzumab-resistant, advanced breast cancer
Publication date :
December 2013
Event name :
San Antonio Breast Cancer Symposium
Event place :
San Antonio, United States
Event date :
10-14 December 2013
Audience :
International
Journal title :
Cancer Research
ISSN :
0008-5472
eISSN :
1538-7445
Publisher :
American Association for Cancer Research, Inc. (AACR), Baltimore, United States - Maryland
